Chemclin Diagnostics Co., Ltd. (SHA:688468)

Chemclin Diagnostics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	401.23	400.25	448.66	342.14	311.63	224.82
Trading Asset Securities	486	509	470	643	613	328.57
Cash & Short-Term Investments	887.23	909.25	918.66	985.14	924.63	553.39
Cash Growth	1.02%	-1.02%	-6.75%	6.54%	67.08%	-5.10%
Accounts Receivable	19.28	20.31	25.29	34.06	35.13	31.28
Other Receivables	3.67	3.87	6.48	2.94	3.21	3.25
Receivables	22.95	24.18	31.77	37.01	38.34	34.52
Inventory	110.59	109.26	110.61	112.56	122.36	98.67
Other Current Assets	29.09	24.99	41.59	30.55	5.96	15.75
Total Current Assets	1,050	1,068	1,103	1,165	1,091	702.34
Property, Plant & Equipment	485.7	483.65	495.01	223.44	157.85	125.54
Goodwill	153.76	153.76	153.76	153.76	153.76	153.76
Other Intangible Assets	39.94	41.48	34.24	13.97	13.75	14.07
Long-Term Deferred Tax Assets	33.5	31.51	22.08	15.17	10.7	4.02
Long-Term Deferred Charges	52.84	54.08	12.84	19.59	3.55	7.1
Total Assets	1,816	1,832	1,821	1,591	1,431	1,007
Accounts Payable	36.2	66.63	90.24	67.75	22.03	32.04
Accrued Expenses	8.06	17.99	22.22	38.88	24.13	15.26
Current Portion of Long-Term Debt	-	20.19	-	-	-	-
Current Portion of Leases	29.45	5.25	6.66	10.9	11.39	-
Current Income Taxes Payable	9.24	4.88	9.61	16.48	9.28	6.5
Current Unearned Revenue	7.37	9.6	6.91	4.58	3.57	5.4
Other Current Liabilities	57.03	58.81	58.5	58.67	51.16	45.53
Total Current Liabilities	147.35	183.35	194.13	197.25	121.56	104.73
Long-Term Debt	200.19	200.19	196.67	-	-	-
Long-Term Leases	29.67	24.12	31.28	1.57	13.22	-
Long-Term Unearned Revenue	-	-	-	-	5	5
Long-Term Deferred Tax Liabilities	7.53	8.18	9.68	11.77	12.46	9.73
Total Liabilities	384.74	415.85	431.76	210.59	152.23	119.46
Common Stock	401.11	401.11	401	401	401	360
Additional Paid-In Capital	565.66	565.66	564.92	564.92	547.48	339.92
Retained Earnings	515.17	500.63	422.88	414.65	330.2	187.44
Treasury Stock	-51.09	-51.09	-	-	-	-
Shareholders' Equity	1,431	1,416	1,389	1,381	1,279	887.36
Total Liabilities & Equity	1,816	1,832	1,821	1,591	1,431	1,007
Total Debt	259.31	249.76	234.61	12.47	24.6	-
Net Cash (Debt)	627.92	659.5	684.05	972.67	900.03	553.39
Net Cash Growth	-0.44%	-3.59%	-29.67%	8.07%	62.64%	-5.10%
Net Cash Per Share	1.60	1.66	1.72	2.42	2.33	1.56
Filing Date Shares Outstanding	363.57	394.59	401	401	401	360
Total Common Shares Outstanding	363.57	394.59	401	401	401	360
Working Capital	902.51	884.33	908.49	968	969.74	597.61
Book Value Per Share	3.94	3.59	3.46	3.44	3.19	2.46
Tangible Book Value	1,237	1,221	1,201	1,213	1,111	719.54
Tangible Book Value Per Share	3.40	3.09	2.99	3.02	2.77	2.00
Buildings	-	306.04	-	-	-	-
Machinery	-	446.91	391.37	381.13	383.66	358.7
Construction In Progress	-	0.58	365.61	103.13	7.57	0.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.